» Articles » PMID: 39766786

The Chicken Promoter and Its Regulation by MYC and HIF1A

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2025 Jan 8
PMID 39766786
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Histone deacetylase 4 () is a member of the class II histone deacetylase family, whose members play a crucial role in various biological processes. An in-depth investigation of the transcriptional characteristics of chicken can provide fundamental insights into its function.

Methods: We examined expression in chicken embryonic stem cells (ESC) and spermatogonial stem cells (SSC) and cloned a 444 bp fragment from upstream of the chicken transcription start site. Subsequently, we constructed pEGFP-HDAC4 and a series of 5'-deletion luciferase reporter constructs, which we transfected into DF-1 cells to measure their transcriptional activity. The regulatory mechanisms of chicken expression were investigated by performing trichostatin A (TSA) treatment, deleting putative transcription factor binding sites, and altering transcription factor expression levels.

Results: exhibited higher expression in SSC than in ESC. We confirmed that the upstream region from -295 bp to 0 bp is the core transcriptional region of . TSA effectively inhibited transcription, and bioinformatics analysis indicated that the chicken core promoter sequence exhibits high homology with those of other avian species. The myelocytomatosis viral oncogene homolog (MYC) and hypoxia-inducible factor 1 α (HIF1A) transcription factors were predicted to bind to this core region. Treatment with TSA for 24 h resulted in the upregulation of MYC and HIF1A, which repressed transcription.

Conclusions: Our results provide a basis for subsequent investigations into the regulation of expression and biological function.

References
1.
Morimoto H, Yamamoto T, Miyazaki T, Ogonuki N, Ogura A, Tanaka T . An interplay of NOX1-derived ROS and oxygen determines the spermatogonial stem cell self-renewal efficiency under hypoxia. Genes Dev. 2021; 35(3-4):250-260. PMC: 7849365. DOI: 10.1101/gad.339903.120. View

2.
de Sousa G, Salomao K, Nagano L, Riemondy K, Chagas P, Veronez L . Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas. Cancer Gene Ther. 2023; 30(8):1105-1113. DOI: 10.1038/s41417-023-00616-z. View

3.
Guan Y, Yang X, Wei L, Chen Q . MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. FASEB J. 2011; 25(12):4457-66. PMC: 3236620. DOI: 10.1096/fj.11-185132. View

4.
Kurdistani S, Tavazoie S, Grunstein M . Mapping global histone acetylation patterns to gene expression. Cell. 2004; 117(6):721-33. DOI: 10.1016/j.cell.2004.05.023. View

5.
Yuan J, Yang F, Chen B, Lu Z, Huo X, Zhou W . The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma. Hepatology. 2011; 54(6):2025-35. DOI: 10.1002/hep.24606. View